Injectable Drug Compatibility News

In this update we added new drug monographs for CEFTAZIDIME AND AVIBACTAM, CEFTOLOZANE AND TAZOBACTAM, and SUGAMMADEX. Also, we added new stability information for these drugs:  AMPICILLIN SODIUM, LABETALOL HYDROCHLORIDE, PIPERACILLIN AND TAZOBACTAM, POLYMYXIN B SULFATE, and PROPAFENONE HYDROCHLORIDE. In addition new compatibility information is reported for ESMOLOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE, and METOPROLOL HYDROCHLORIDE, each in combination with 14 different drugs. Overall, new compatibility information is included for over 90 unique drug pairs in this supplement.

In this supplement we added new drug monographs for DEFIBROTIDE SODIUM, CLEVIIDIPINE, IPILIMUMAB, and POSACONAZOLE. Also, we added new stability information for these drugs: AZACITIDINE, BENDAMUSTINE HYDROCHLORIDE, DEFEROXAMINE MESYLATE, DOXARUBICIN HYDROCHLOIRIDE, ERTAPENEM, GANCICLOVIR SODIUM, and MELPHALAN. In addition new compatibility information is reported for LEVOFLOXACIN, MOXIFLOXACIN, NOREPINEPHRINE BITARTRATE, PIPERACILLIN AND TAZOBACTAM, TRAMADOL HYDROCHLORIDE, and VANCOMYCIN HYDROCHLORIDE.

In this supplement we added new drug monographs for CANGRELOR (including compatibility information with 99 drugs), and for TEDIZOLID (including compatibility information with 86 drugs). Also, we added new stability information for fifteen drugs: ABCIXIMAB, ALFENTANIL HYDROCHLORIDE, ALTEPLASE, AZITHROMYCIN DIHYCLATE, BUPIVACAINE LIPOSOME, CO-TRIMOXAZOLE, DAPTOMYCIN, DIGOXIN, ERTAPENEM, MICAFUNGIN SODIUM, MILRINONE LACTATE, PROPOFOL, QUINUPRISTIN AND DALFOPRISTIN, ROPIVACAINE HYDROCHLORIDE and ZICONOTIDE. In addition new compatibility information is reported for BUPIVACAINE LIPOSOME AND ZICONOTIDE.